Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy

Table 1

HP-eradication: univariate analysis.

Independent variables	Subgroups analysed	HP eradication rate	𝑃 value
L. reuteri supplementation	Y	36 (80%)	0.038
	N	27 (60%)
Age	<42 y	33 (73.3%)	0.782
	≥42 y	30 (66.7%)
Sex	Male	40 (88.9%)	0.329
	Female	23 (51.1%)